Kliniken Maria Hilf GmbH

Hospital


Location: Mönchengladbach, Germany (DE) DE

ISNI: -

ROR: https://ror.org/01wvejv85

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial (2017) Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer G, Hartmann A, et al. Conference contribution Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society (2017) Kowalski C, Graeven U, Von Kalle C, Lang H, Beckmann M, Blohmer JU, Burchardt M, et al. Journal article Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer (2017) Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, Hartmann A, et al. Journal article Generation Y : Problem or solution in daily clinical practice (2016) Goebell P, Salem J, Strunk J, Stahl L, Oelke M, Sommerkamp HJ, Schwaibold R, et al. Journal article Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management (2016) Windfuhr JP, Toepfner N, Steffen G, Waldfahrer F, Berner R Journal article Clinical practice guideline: tonsillitis II. Surgical management (2016) Windfuhr JP, Toepfner N, Steffen G, Waldfahrer F, Berner R Journal article Analgetische Effekte körperlich-sportlicher Aktivität auf den Geburtsschmerz (2015) Reimers AK, Schwennicke G Journal article, Review article Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial (2015) Roedel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, et al. Journal article
1 2 3 4